Preventing avoidable central line–associated bloodstream infections: Implications for probiotic administration and surveillance

Central line-associated bloodstream infections (CLABSIs) are a source of morbidity and impose an important financial burden. As a public safety net health system, we continually strive to improve the quality of our care and to minimize cost. Every health care-associated infection is scrutinized to a...

Full description

Saved in:
Bibliographic Details
Published in:American journal of infection control 2016-11, Vol.44 (11), p.1427-1428
Main Authors: Skljarevski, Sonja, MD, Barner, Amanda, PharmD, BCPS, Bruno-Murtha, Lou Ann, DO
Format: Article
Language:English
Subjects:
Aged
Bacteremia - prevention & control
Catheter-Related Infections - prevention & control
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - microbiology
Diabetes Mellitus, Type 2 - therapy
Disease prevention
Enteral Nutrition
Female
Humans
Infection Control
Infectious Disease
Lactobacillus
Morbidity
Nosocomial infections
Probiotics
Probiotics - administration & dosage
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Central line-associated bloodstream infections (CLABSIs) are a source of morbidity and impose an important financial burden. As a public safety net health system, we continually strive to improve the quality of our care and to minimize cost. Every health care-associated infection is scrutinized to assess whether it could have been prevented. To our surprise, one patient recently fulfilled the National Healthcare Safety Network (NHSN) surveillance definition for a CLABSI in a situation which could have been avoided if probiotics were more carefully handled.
ISSN:0196-6553
1527-3296
DOI:10.1016/j.ajic.2016.07.029